The latest price target for Veradigm (OTCEM:MDRX) was reported by Stephens & Co. on January 31, 2025. The analyst firm set a price target for $13.00 expecting MDRX to rise to within 12 months (a possible 152.43% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Veradigm (OTCEM:MDRX) was provided by Stephens & Co., and Veradigm maintained their equal-weight rating.

The last upgrade for Veradigm Inc happened on December 7, 2022 when Argus Research raised their price target to $26. Argus Research previously had a hold for Veradigm Inc.

The last downgrade for Veradigm Inc happened on March 19, 2024 when Deutsche Bank changed their price target from $15 to $10 for Veradigm Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Veradigm, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Veradigm was filed on January 31, 2025 so you should expect the next rating to be made available sometime around January 31, 2026.

While ratings are subjective and will change, the latest Veradigm (MDRX) rating was a maintained with a price target of $7.00 to $13.00. The current price Veradigm (MDRX) is trading at is $5.15, which is out of the analyst’s predicted range.